Abstract: Chronic disease (care) management (CDM) is a patientcentered model of care that involves longitudinal care delivery; integrated, and coordinated primary medical and specialty care; patient and clinician education; explicit evidence-based care plans; and expert care availability. The model, incorporating mental health and specialty addiction care, holds promise for improving care for patients with substance dependence who often receive no care or fragmented ineffective care. We describe a CDM model for substance dependence and discuss a conceptual framework, the extensive current evidence for component elements, and a promising strategy to reorganize primary and specialty health care to facilitate access for people with substance dependence. The CDM model goes beyond integrated case management by a professional, colocation of services, and integrated medical and addiction care-elements that individually can improve outcomes. Supporting evidence is presented that: 1) substance dependence is a chronic disease requiring longitudinal care, although most patients with addictions receive no treatment (eg, detoxification only) or short-term interventions, and 2) for other chronic diseases requiring longitudinal care (eg, diabetes, congestive heart failure), CDM has been proven effective.
S
ubstance (alcohol and drug) dependence is a chronic disease for which many affected adults receive no intervention or detoxification without subsequent treatment. Like other chronic diseases (eg, diabetes, congestive heart failure), substance dependence has no cure and is characterized by relapses requiring longitudinal care. Medical and psychiatric comorbidities are the rule rather than the exception. As a result, care delivery can be complex both for clinicians and patients. In the United States, systems of care for substance dependence (both alcohol and drug) are rarely integrated with those for medical and psychiatric illnesses. Specialty alcohol and drug treatment is efficacious, but many patients do not access available treatment for substance dependence problems after detoxification or medical care. Others enter specialty addiction treatment but do not receive medical or psychiatric care. Some have called to expand the frame of health services research on addictions to include services outside the specialty treatment sector, including behavioral care integrated into primary care. [1] [2] [3] Although primary care settings provide the venue for longitudinal, comprehensive, and coordinated care, their potential to effectively treat addiction and related comorbidities has not been realized; medical, mental health, and addiction treatment are not coordinated. Primary care settings, with reorganization and appropriate service elements, hold the promise of simultaneously improving physical and psychiatric health while decreasing substance dependence problems. Although chronic disease management-longitudinal care delivery linking, integrating, and coordinating primary and specialty health care-is effective for other diseases, it has not been described or studied for substance dependence.
CHRONIC DISEASE (CARE) MANAGEMENT
Chronic disease (care) management (CDM) is based on a chronic care model, as described by Wagner et al. 4 -6 Chronic disease (care) management is a patient-centered model of care, which includes patient and clinician education, explicit evidence-based care plans, and expert care availability (Table 1 ). In using the term "disease management," this article is about health services based on Wagner's model and not about corporate programs that focus primarily on patient self-care and are implemented via telephonic contacts. 7 
CDM CONCEPTUAL FRAMEWORK
Many, including the Institute of Medicine (IOM), have recognized the challenge of managing chronic conditions in a health care system designed to treat acute illness. 8 In 1996, Wagner et al. proposed a solution-CDM 4 -6 -based on a chronic care model. Chronic disease management is implemented by the following multidisciplinary team members: nurse clinical care managers with disease-specific skills to coordinate referrals, communicate with clinical caregivers, and proactively follow patients; social workers to access community resources; and physician specialists. The U.S. Center for Medicare and Medicaid Services (CMS) and the National Committee for Quality Assurance (NCQA) have recognized the potential of CDM. 9 -11 Policy analysts have called for CDM to be integrated into primary care settings to avoid fragmented care. [12] [13] [14] [15] We argue that chronic disease management could be applied to addiction for patients in the primary care setting, particularly those who are out-of-treatment. 6 Of U.S. adults, 23 million have substance dependence, costing society almost $300 billion each year, yet 90% of people with addictions are out-of-treatment because of individual barriers and a fragmented treatment system. 16 -23 Thus, although addictions treatment is effective and reduces health care costs, its benefits are largely unrealized.
In addition to the chronic care model, 2 additional conceptual models support the categories and elements specified in a CDM approach applied to addictions: D'Aunno 24 and others' integrative linkages of health services, and Andersen's 25 behavioral model of health services utilization. D'Aunno and others have proposed that stronger linkages between care systems and clinicians (eg, case management [CM]), "colocated" services, more formal referral arrangements) can increase the likelihood of addictions treatment entry and completion. 24 Specialty substance dependence treatment reduces the risk for relapse. Medical and psychosocial services can help to prevent relapse and can help decrease barriers to substance dependence treatment, but patients face substantial systemic and personal barriers to receiving these services, as well as in accessing addiction specialty treatment (eg, insurance problems, personal disorganization, care systems focused on patients with one problem, privacy issues, bureaucracy, motivation). 26 Integrative linkages can align these services. Stronger linkage mechanisms increase the probability that patients will obtain needed services. The strongest linkage mechanism is on-site service delivery. To go beyond this structural solution, we conceptualize integrated, professionally delivered case management as a key component of CDM and as a health system-enabling resource as described in Andersen's model. 25 This resource helps the patient to increase recognition of needs (eg, substance dependence treatment, attention to medical and psychosocial needs) and to improve the use of health services ("effective access") that improve health status. Friedmann et al. 27, 28 reported that drug use decreased among addiction treatment patients who had comprehensive services matched with identified needs. Thus, effective matching of service to need, one goal of CDM, can be a useful addiction treatment practice. In addition to these common elements that address systems issues and health and social problems, CDM tailored for addiction would include individual addiction-specific interventions. These elements are chosen based on their proven efficacy, their appropriateness for patients who have not entered treatment, their compatibility with health care organization theories, and primary care setting constraints. These addiction treatment components are each supported by their own theoretical frameworks: motivational interviewing by theories of behavior change 29, 30 ; case management by therapeutic alliance and enhancing receipt of needed services 31, 32 ; medication by theories of neuronal receptor involvement in alcohol and drug dependence 33, 34 ; complete health (medical, psychologic, social) and needs assessment, feedback, and advice delivered by an empathic clinician by the biopsychosocial model of addictions requiring pharmacotherapy, psychosocial support and services 35 ; management of detoxification to avoid substance use to relieve withdrawal symptoms 36, 37 ; and relapse prevention in primary care. 38, 39 Based on recent outcomes research, CDM for substance dependence could base recommendations for self-help involvement on an egalitarian model (offer to all regardless of individual need factors) and a need-based model for additional services. 40 Finally, researchers have made a case for extended recovery monitoring interventions for alcohol and drug disorders. 41 In a randomized trial of patients with alcohol or cocaine dependence, 3 months of weekly telephone monitoring was added to group counseling sessions started after completion of intensive outpatient treatment. Total abstinence was more common 2 years later in the telephone monitoring group. 41 Similarly, other researchers have noted benefits from "recovery management check-ups." 42 
APPLICATION OF CDM TO ADDICTIONS
Wagner and colleagues proposed the chronic care model and the elements of effective chronic disease management (Table 1) . 4 -6,43,44 How should these elements work if applied to addiction care? As shown in Figure 1 , in CDM, clinicians are expert, identify problems (disease of interest as well as medical, social, emotional), share information with patients and teach problem solving skills. Patients identify problems, set goals, and change behavior based on internal motivation. Multidisciplinary teams, including a nurse care manager, social worker and clinicians with expertise in the disease of interest, and expertise in common comorbidities, can spend time with the patient, coordinate with primary care physicians (PCPs), address necessary releases of information, and facilitate specialist referrals, provide access to community resources, implement evidence-based protocols, encourage self-management, and be proactive about follow-up. Information can be shared across team members, primary care clinicians, and specialists by using electronic records creating virtual colocation of care even when clinicians are in separate physical locations. This same information, when aggregated in a registry, can support the attention of the team to individual patients who have not received needed care and to clinical outcomes. In sum, an informed, motivated patient and a prepared, proactive team and delivery system lead to optimal chronic disease care and improved outcomes.
How could CDM elements be implemented in primary care for addiction? Figure 2 categorizes the specific elements of a proposed CDM intervention for substance (alcohol or drug) dependence into 3 areas: systems; medical, psychiatric and social problems; and addiction specific components and related outcomes. The systems changes follow directly from the elements in Table 1 .
This approach is needed in part because of the current fragmentation of the treatment system, a system that only infrequently incorporates efficacious treatment elements. Although addiction treatment services often exist, and may be available in the sense that services are covered by insurance or grant funded, many barriers still prevent most patients from accessing these services. In fact, specialty services are not truly accessible at the time or in the settings in which patients are present. Chronic disease management, involving strong linkages within and between systems of care, integrated case management, and known effective addictions treatment components delivered under one roof, is hypothesized to increase the likelihood that patients will access and receive effective treatment for substance dependence problems, re-engage in care when they drop out, improve utilization of medical and other health services, and be less likely to suffer consequences of alcohol and drug use. These hypotheses are based on a careful review of the literature that we present in the section that follows regarding the chronic nature of addiction, fragmentation of care, suboptimal access to effective addiction care, and evidence for the individual components of the proposed CDM model.
ADDICTION: A CHRONIC DISEASE WITH PSYCHIATRIC AND MEDICAL COMORBIDITY
Whereas current care utilization is episodic (ie, detoxification only), the course of substance dependence often is chronic, particularly in people who seek and receive treatment. In a population-based sample, not a treatment sample, the mean duration of an episode of alcohol dependence was 3.7 years, and 28% of people had more than 1 episode (average, 5 episodes). 45 As with chronic medical illnesses, addiction is associated with chronic physiologic changes, a relapsing course, no "cure," variable adherence to care, and the need for ongoing care. 46, 47 In addition to social, legal and family consequences, medical, and psychiatric disorders (eg, depression) are common (ie, 30 -50%) and can be triggers for relapse. 38,48 -54 When patients seek care for substance dependence, they are more likely than others to have myriad conditions: injury/overdose, anxiety, depression, psychosis, low back pain, headache, arthritis, asthma, acid-related peptic disorders, chronic obstructive pulmonary disease, hepatitis C, hypertension, alcoholic gastritis, diseases of the pancreas, and cirrhosis. 55, 56 Because addiction can decrease medication adherence and other self-care, the care of these other medical and psychiatric conditions becomes more complex. 57 
FRAGMENTED ADDICTION TREATMENT
Elements of the proposed model of CDM provide strategies to reduce entry barriers to effective addiction treatment and to promote continuous patient engagement in some level of care. The current treatment system is fragmented among acute medical and specialty alcohol and drug services with little coordination. 58 -60 Furthermore, few patients in recovery report having ever had formal treatment 61 and only 18% of adults with addiction report seeking mental health or addictions treatment annually. 19 Detoxification is a possible entry point to the treatment system but the missing linkage from detoxification, not a treatment itself, to treatment is recognized at the national level. 62 Privacy protection may interfere with coordinating linkage between treatment systems. However, the period after detoxification is a time of crisis during which mortality is substantial. 63 Barriers to treatment entry and continuous care include patient, treatment program, and systems factors. True accessibility 64 or "effective access" 25 is frequently missing, and only half of individuals entering treatment complete care episodes even 
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Chronic Disease Management for Addiction though current programs are generally short-term. 65 Low rates occur despite the fact that financial barriers may be low, addiction treatment often is available without health insurance, 66 and persons with addictions generally live close to treatment programs, an average of 3.2 miles, although this availability is not consistent. 67 The treatment system may not be offering what the patient wants or can use. Patient factors include motivation, employment issues, attitudes, and beliefs, 68 -71 and other comorbid medical and psychiatric problems can interfere with access to care. For example, a treatment program may preclude patients from concomitant use of psychiatric medication. These barriers can make "usual care," effectively no care, or, at best, suboptimal care for alcohol and drug dependence. Elements of CDM have the potential to address many of these barriers (Table 1; Figs. 1 and 2).
UNDERUTILIZED EFFICACIOUS TREATMENTS
Case management, pharmacotherapy (eg, naltrexone and buprenorphine), brief interventions, social skills training, community reinforcement approaches, behavior contracting, motivational interviewing, motivational incentives, and marital therapy are effective treatment elements that are currently underutilized for which use could be increased by CDM. 52, [72] [73] [74] [75] [76] [77] [78] [79] [80] Pharmacological treatments are underused in the addiction system, which emerged outside of medical care settings. The orientation of the system is toward short-term interventions. 81 Treatment philosophy, particularly 12-step orientation, may run counter to any psychotropic drug use. 82, 83 Health professionals have varied medical skills and qualifications (eg, ability to prescribe or administer medication 84 ), and many lack both familiarity with addiction medications and ancillary support for its management. 85 Nevertheless, new interventions for addiction treatment particularly well suited to medical settings include "medical management" as tested in the COMBINE study 86 and used in the BRENDA (Biopsychosocial evaluation, Report, Empathy, Needs, Direct advice, Assessment) approach. BRENDA has primarily been used to support pharmacotherapy of alcoholism.
Although not yet tested in a randomized trial nor used for patients with drug dependence, controlled studies have found use of BRENDA to be associated with improved medication adherence, retention in treatment, and improved clinical outcomes. 35, 87, 88 Preliminary data from primary care studies suggest that training to use such guidelines leads to clinician-based discussions about relapse risk. 38, 89 FIGURE 2. How chronic disease management (CDM) components address specific problems to lead to improved health.
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INSUFFICIENT LINKAGE OF ADDICTION TREATMENT AND PRIMARY MEDICAL CARE
Options for linkage of addiction and primary medical care treatment have primarily included distributive approaches, in which patients in one system are referred to another resulting in tenuous links. 59 Few patients with addictions access medical care and informal referrals from addictions treatment do not increase access. 24, 90 Conversely, patients in medical settings are often not identified or referred to addiction treatment. [91] [92] [93] In 1991, a Federal conference concluded that better linkage should be pursued by colocating services and improving the effectiveness of referrals. 94 This conclusion remains relevant today.
A parallel problem exists for primary care providers accessing mental health services, an element of care also in short supply and often comorbid with substance dependence. 92, 95 Primary care physicians have been challenged to play a larger role in addressing patients' mental health needs. 96 -100 Some clinical models use a mental health team in the primary care clinic to rapidly evaluate and stabilize patients, and educate the primary care clinical staff. 99, 100 In these integrated approaches receipt of mental health services increase, referrals decrease, patients benefit by continuing to be treated by their primary care physicians, and physicians benefit from additional support and training from mental health professionals. A quality improvement initiative for depression care management in primary care practices enhanced effectiveness and outcomes, leading an editorialist to conclude that "Evidence that depression outcomes can be improved through systematic changes in delivery of care is now compelling." 101, 102 In another model, a Veterans Affairs mental health clinic 103 successfully integrated medical care emphasizing preventive measures, patient education, and close collaboration with mental health providers and patients had significant improvements in quality and outcomes of medical care. Mechanic 104 notes that although few systems successfully integrate care at the clinical level, simply having a clinician meet a community provider to whom patients with schizophrenia would be linked improved continuity of care and symptom improvement. 105 These mental health studies demonstrate the importance of discrete systemic innovations to improve access and clinical and utilization outcomes. Thus, although interorganizational integration and coordination of care has been difficult to achieve, when achieved, outcomes are improved. 106 -108 Intraorganizational interventions, such as CDM, have been proven feasible and effective and form the basis of the proposed model of CDM for addictions. Chronic disease management improves patient adherence to treatments and disease control compared with usual care and relies on patient education and reminders, and clinician education and feedback. 109 -111 Compared with usual care, CDM interventions focus on a disease but attend to comorbidity. A major strength and promise of such interventions is improvement in the disease of focus as well as comorbidities. [101] [102] [103] [112] [113] [114] [115] Although no trials of CDM for addiction appear in the literature, systematic reviews have identified numerous controlled studies of CDM for psychiatric illnesses and inform the choice of effective elements for addictions. For example, a large randomized trial of a depression CDM intervention found that CDM patients were more likely to receive depression treatments and have a significant reduction in depressive symptoms and functional impairment 116 and improved arthritis pain and functional outcomes. 117 In this CDM intervention, patients received a 20-minute educational video and booklet about depression, a visit with a trained depression nurse or psychologist care manager in primary care, underwent medical and psychosocial assessment, and were asked about their treatment preferences. The team suggested antidepressant medication (80% had 1 trial of medication) or brief psychotherapy adapted for the primary care setting delivered by the case manager (30% received this counseling). Thus, the team offered services tailored to patients' needs and preferences rather than attempting to provide a specific treatment to all subjects regardless of preference or need. Patients were contacted by telephone (mean, 6 times) or visited the clinic every other week (mean, 9 visits). When symptoms persisted, the team, including a specialist (psychiatrist), intervened. The depression CDM intervention included focus on a medical condition if the patient wished.
Rost et al. 118 randomized 211 adults with major depression to usual primary medical care or to a CDM intervention group. An "initial intervention" was a visit with a trained office nurse to assess depressive symptoms, provide education about treatment options, address readiness to engage in treatment, and arrange follow-up. In the "continuing intervention," nurse care managers phoned patients to encourage adherence and to advise them to raise problems with their physicians. The content was tailored to whether the patient was symptomatic. Nurse care managers provided physicians with reports of patients' symptoms and treatments, and a psychiatrist provided treatment guidelines. Chronic disease management increased remission of depression and improved emotional and physical functioning.
Simon et al. 119 compared CDM with usual medical care for depression. Chronic disease management included telephone assessments of depressive symptoms and treatments, calls to those who discontinued treatments, assistance with appointments, reports to primary care physicians on patient progress with depression treatment recommendations, and suggestions to contact patients to schedule follow-up visits as needed. A psychiatrist supervised the CDM team. Chronic disease management improved prescription of appropriate doses of medication and decreased depressive symptoms and the incidence of major depression compared with usual care.
Hedrick et al. 120 tested CDM for depression compared with usual primary care, in which psychiatrists were available for referrals in primary care. Care was by a multidisciplinary team in primary care consisting of a psychologist, psychiatrist, social workers, and a psychology technician. The team implemented evidence-based care (antidepressants and 6 sessions of cognitive behavioral therapy), communicated with primary care physicians, took patient preferences into account, proactively monitored patient symptoms and treatment barriers, and provided patient education. Chronic disease management increased the proportion of patients receiving effective therapies for depression and was associated with
Chronic Disease Management for Addiction improved depressive symptoms and mental health-related quality of life. Because substance dependence is associated with significant medical illness and cost consequences, the evidence regarding CDM for medical illnesses also is relevant. Chronic disease management for heart failure, diabetes, arthritis and asthma, in randomized, controlled studies [121] [122] [123] [124] [125] [126] and in systematic reviews of more than 100 trials 43, 44, 127 leads to clinical and functional improvement, decreased hospitalizations, treatment adherence, and patient satisfaction. Health systems adopting these programs report improved outcomes. 44 Of note, Whellan et al.'s 126 intervention, in addition to addressing the target chronic disease of heart failure directly, also included "other strategies targeted at optimizing the control of concomitant illnesses that may worsen" heart failure. A lesson for addictions care might be to include care for common comorbid medical and psychiatric illnesses in substance dependence CDM.
Evidence for effectiveness of CDM for psychiatric and medical illnesses is strong. Because addiction has similarities with these chronic illnesses, CDM has potential for improving addiction outcomes.
ELEMENTS OF CDM FOR ADDICTION PROVEN EFFECTIVE
A Medline search from 1966 through late 2007 for "disease management" and "alcoholism" or "drug dependence" yielded few results, none of which included controlled trial evidence for the effectiveness of CDM for addiction. Given the lack of relevant published studies, we reviewed the evidence for 2 key components, which when combined would reflect on the potential benefit of CDM when studied in patients with addiction: a) integrated case management delivered by professionals, and b) integrative linkage of medical, psychosocial, and alcohol and drug dependence care.
Case management coordinates and links patients with appropriate services to address specific needs across systems of care, 32, 128, 129 and in this model is delivered by a skilled nurse or social worker. Case management includes patient assessment, care planning and coordination, linkage to services, outcome monitoring, and advocacy for patients, in a single point of contact, for addiction, medical, and other services (eg, family services, self-help groups, insurance, food, housing, transportation, and employment). In alcohol and drug treatment practice, the CM definition is quite varied, 32, 130, 131 may be delivered by paraprofessionals or peers, and not all models are effective. When CM and addiction treatment are delivered by one clinician, the approach is more effective than case management alone. 32 One key ingredient is therapeutic alliance. 132 This alliance impacts homelessness, 31 treatment participation, drinking, 133 and drug treatment retention and outcome, 134, 135 particularly for those with more severe psychiatric problems. 136 Case management can increase linkage from substance abuse treatment to primary medical care. 48 Case management also can decrease relapse and increase retention in addictions treatment. 137 McLellan et al. compared outpatient group counseling twice per week with counseling and case management in a quasi-experimental study in patients admitted to addiction treatment. [15] [16] [17] [18] [19] [20] Case management was associated with greater receipt of alcohol, medical, psychiatric, employment, and family services, and with less alcohol intoxication (and lower severity), and fewer days of psychiatric and medical problems. 75 In a similar study, 52 Case management improved alcohol use, medical, employment, legal, and family status. Stout et al. 130 compared case monitoring aftercare delivered by skilled clinicians (case management plus reassessment and ongoing advice) for patients with alcohol abuse or dependence discharged from day hospital to standard referrals to outpatient follow-up. Case monitors met with subjects for 30 minutes and then by telephone monthly or less for 2 years. The interactions included constant reassessment, were supportive and nonjudgmental, and addressed substance use and other major life problems by referral. Recommendations depended on patient needs. Preliminary results were a 50% decrease in heavy drinking and fewer emergency visits in the CM group. 41, 138 Dennis et al. 42 found that quarterly case management delivered by phone for patients in early recovery led to more appropriate treatment utilization.
A second element involves organizational restructuring: integration and "colocation" of services to achieve integration and continuity of care. 139 -142 Studies of colocation have found that patients with addictions who receive both regular addiction and medical care were less likely to be hospitalized than those who received one or neither service, 143 and on-site medical service provision, transportation, and CM increased receipt of medical services. 144 -150 Friedmann et al. 151 found that provision of primary medical care by off-site referral or on-site at drug treatment programs, compared with no such mechanism, reduced emergency, and hospital utilization.
Furthermore, on-site primary care at addiction programs has been associated with reduced addiction severity. 152 In a randomized trial, patients receiving on-site medical, psychiatric, employment, and family services had less opiate use, and improved medical, employment, legal and psychiatric outcomes. 74 Women with psychiatric problems were more likely to complete outpatient addictions care when offered psychiatric care. 153 In a trial that randomized veterans without primary care who were entering substance abuse treatment with a chronic medical condition to receive primary medical care either on-site or off-site, on-site care increased access to primary care and addiction treatment retention. 154 On-site alcohol and drug treatment in primary care also can improve alcohol and drug use outcomes and be safe and effective. [155] [156] [157] [158] [159] In clinical trials, naltrexone for alcoholism was efficacious when given with primary care management. 160 Similar findings of success of acamprosate in primary care have been reported. 161 Furthermore, one study reported that 78% of patients receiving office-based buprenorphine for opiate dependence remained in care compared with 52% of patients in a traditional drug treatment center. 158 In a unique model, Weisner et al. 162 randomized 592 adults to usual, separate primary care, or integrated primary care at an addictions treatment program by 3 primary care physicians with specialty addictions training, a medical assistant, and 2 nurses. There were no overall differences in abstinence, but in a subgroup of patients with substance abuse-related medical conditions (57%), on-site care was associated with increased abstinence at 6 months. In a randomized trial in a special alcohol clinic for veterans, 163 the integrated care group was more likely to be abstinent than a usual care group (74% versus 49% 30-day abstinence). 164 The study intervention was focused on alcoholism but included substantial attention to comorbidity. The intervention was an initial thorough inpatient evaluation by a multidisciplinary team who developed a care plan to reduce alcohol severity and remission of related medical conditions. The plan included monthly primary care visits to review drinking and medical problems at a frequency indicated by clinical status and feedback of blood test results to encourage abstinence. Mental health and social services and more intensive alcohol treatment were provided on-site when necessary. Patients were contacted when they missed appointments. In a recent prospective study, 165 patients with alcohol dependence were referred to Alcoholics Anonymous; when most refused to attend, the study provided monthly extensive visits with a medical nurse who was available for telephone consults, and brief visits with a gastroenterologist. Drinking decreased from 16 to 2.5 drinks per day.
Andersen et al. 166 studied 45 adults cared for by a nurse care manager who addressed both their HIV and substance abuse, accompanying patients to physician visits and facilitating integration of medical and substance abuse treatment recommendations. Addiction severity and health-related quality of life improved significantly in this sample during 6 months. Bartels et al. 167 studied 2022 elderly patients with a mental health disorder and/or at-risk drinking, randomizing them to integration and colocation of mental health and substance abuse services in primary care, or to facilitated referral, including scheduling and payment, and transportation, to specialty mental health, or substance abuse clinics. The integrated model was associated with greater attendance at mental health and substance abuse treatment. This body of research, both randomized controlled trials and cohort studies, supports the concept that integration of addiction, mental health, and medical services yields improvements in adherence to care, severity of substance use, and appropriate utilization of services.
CONCLUSIONS
Substance dependence is a common and costly chronic illness associated with medical and psychiatric comorbidity. Treatment can be efficacious when it is actually received by patients. But the current system of care is fragmented, not coordinated, and does not always include proven efficacious treatments. Patient motivation and coexisting health and social problems are barriers to receipt of effective treatment. Integrated and coordinated care, which simultaneously addresses patient motivation and needs across health domains, provides efficacious addiction treatments and facilitates effective access to other treatment. This integrated care may increase the likelihood that care is received and that addiction-related and other clinical outcomes improve. The World Health Organization called the management of chronic conditions "one of the greatest challenges facing health care systems throughout the world" and recommended building integrated health care as an essential part of the solution. 168 Chronic disease management is a relatively new model to care for chronic psychiatric and medical illnesses and has not been fully applied or disseminated for alcohol or drug dependence. In fact, the leading and latest literature on the topic, prompted by calls from the Institute of Medicine, is silent regarding addictions. 169 More recently, the Institute of Medicine has again, and more specifically, called for improvements in the quality of care for substance use conditions. 170 Chronic disease management is one way to advance this agenda.
Chronic disease management shows promise as an effective strategy for managing substance dependence. It is critical to test the effectiveness of CDM integrated in a primary care setting for substance dependent patients, because this approach can take advantage of the fact that many patients with addictions attend primary care yet do not receive specialty care for their addictions. The current fragmented health service delivery models are limited in many ways for patients with the chronic illness of substance dependence. While we await studies of the effectiveness of CDM in primary care, elements of CDM could be implemented now.
In 1996, we judged from a review of the literature that linking people with addictions with primary medical care 59 held promise, and later we detailed the potential benefits. 58 In a randomized trial, we demonstrated that multidisciplinary assessment and referral increased linkage of people with addictions to primary medical care but found that simple linkage was not enough to improve health. 171 Based on review of the latest literature, the evidence suggests that services delivery models that include case management and integrated care and are modeled on chronic disease (care) management hold promise for improving the care received by people with substance dependence.
